Article
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Cancer research - 1 Aug 2001
Naumann U, Kügler S, Wolburg H, Wick W, Rascher G, Schulz J B, Conseiller E, Bähr M, Weller M
Abstract excerpt
Adenoviral chimeric tumor suppressor 1 (CTS1) gene transfer was evaluated as a novel approach of somatic gene therapy for malignant glioma. CTS1 is an artificial p53-based gene designed to resist various pathways of p53 inactivation. Here, we report that an adenovirus encoding CTS1 (Ad-CTS1) induces growth arrest and loss of viability in all glioma cell lines examined, in the absence of specific cell cycle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
